Trulieve Cannabis Corp. (NYSE:TRLV – Get Free Report) CEO Kim Rivers sold 400,000 shares of Trulieve Cannabis stock in a transaction dated Wednesday, June 24th. The shares were sold at an average price of $8.17, for a total value of $3,268,000.00. Following the completion of the transaction, the chief executive officer owned 1,913,724 shares in the company, valued at $15,635,125.08. This trade represents a 17.29% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Trulieve Cannabis Stock Performance
Shares of NYSE TRLV traded up $0.06 during midday trading on Thursday, hitting $8.56. The stock had a trading volume of 2,007,316 shares, compared to its average volume of 576,130. Trulieve Cannabis Corp. has a 1 year low of $3.50 and a 1 year high of $13.28.
Wall Street Analysts Forecast Growth
A number of research analysts have recently weighed in on the company. Zacks Research upgraded Trulieve Cannabis to a “hold” rating in a research report on Thursday, June 18th. Weiss Ratings began coverage on Trulieve Cannabis in a report on Tuesday, June 16th. They set a “sell (d-)” rating on the stock. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce”.
Trulieve Cannabis Company Profile
Trulieve Cannabis Corp. is a vertically integrated cannabis company focused on the cultivation, processing, and retail sale of medical and adult-use cannabis products. The company offers a range of products that may include flower, pre-rolls, concentrates, edibles, vape products, and topicals through its dispensary network and branded product portfolio.
Trulieve’s operations have been centered primarily in the United States, with a strong presence in Florida and additional markets in other states where cannabis is legally regulated.
Featured Stories
- Five stocks we like better than Trulieve Cannabis
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.
